US07782B1044
US07782B1044
Belite Bio, Inc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.22B EUR | 6.2B EUR | 6.39B EUR | 6.29B EUR |
Enterprise Value | -- | 6.2B EUR | 6.39B EUR | 5.94B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 68.36x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 8.01x | 7.98x | 8.03x | 8.17x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -- | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -0.17% | -0.17% | -0.17% |